LH 📈 Laboratory of America - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5049221055

LH: Blood Tests, Urine Tests, Genetic Tests, Pathology Services, Wellness Services

Labcorp Holdings Inc. is a leading provider of laboratory services, operating through two primary segments: Diagnostics Laboratories and Biopharma Laboratory Services. The company offers a comprehensive range of tests, including blood chemistry analyses, urinalyses, blood cell counts, and various disease-specific tests such as thyroid, PAP, hemoglobin A1C, and vitamin D. Additionally, they provide tests for prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures, and procedures, as well as alcohol and other substance-abuse tests.

Labcorp's specialty testing services include gene-based and esoteric testing, advanced tests targeting specific diseases, and services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. The company also offers health and wellness services to employers and managed care organizations (MCOs), enabling them to make informed decisions about their employees' health and wellbeing.

In addition to its laboratory services, Labcorp provides online and mobile applications that allow patients to access their test results conveniently. The company also offers online applications for healthcare providers, MCOs, and accountable care organizations, making it easier for them to manage patient care. Furthermore, Labcorp provides specimen collection services, drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing.

Labcorp's diverse customer base includes pharmaceutical, biotechnology, medical device, and diagnostics companies, as well as MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. Founded in 1995, Labcorp is headquartered in Burlington, North Carolina, and can be accessed online at https://www.labcorp.com.

Additional Sources for LH Stock

LH Stock Overview

Market Cap in USD 20,253m
Sector Healthcare
Industry Diagnostics & Research
GiC Industry Health Care Providers & Services
TER 0.00%
IPO / Inception 1990-03-29

LH Stock Ratings

Growth 5y 42.2%
Fundamental 8.39%
Dividend 31.6%
Rel. Performance Sector -0.2
Analysts 4.22/5
Fair Price Momentum 230.48 USD
Fair Price DCF 260.82 USD

LH Dividends

Dividend Yield 12m 1.20%
Yield on Cost 5y 2.02%
Annual Growth 5y 20.11%
Payout Consistency 17.41%

LH Growth Ratios

Growth Correlation 3m 67.4%
Growth Correlation 12m 30.1%
Growth Correlation 5y 45.2%
CAGR 5y 11.05%
CAGR/Mean DD 5y 0.75
Sharpe Ratio 12m 0.44
Alpha -23.87
Beta 1.07
Volatility 19.03%
Current Volume 479.8k
Average Volume 20d 663.5k
What is the price of LH stocks?
As of December 04, 2024, the stock is trading at USD 240.57 with a total of 479,848 shares traded.
Over the past week, the price has changed by +0.77%, over one month by +6.22%, over three months by +5.04% and over the past year by +9.79%.
Is Laboratory of America a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Laboratory of America is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.39 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LH as of December 2024 is 230.48. This means that LH is currently overvalued and has a potential downside of -4.19%.
Is LH a buy, sell or hold?
Laboratory of America has received a consensus analysts rating of 4.22. Therefor, it is recommend to buy LH.
  • Strong Buy: 10
  • Buy: 2
  • Hold: 6
  • Sell: 0
  • Strong Sell: 0
What are the forecast for LH stock price target?
According to ValueRays Forecast Model, LH Laboratory of America will be worth about 253 in December 2025. The stock is currently trading at 240.57. This means that the stock has a potential upside of +5.18%.
Issuer Forecast Upside
Wallstreet Target Price 261.1 8.5%
Analysts Target Price 244.1 1.5%
ValueRay Target Price 253 5.2%